Recently acquired by Sygnature Discovery, SB Drug Discovery is a leader in the delivery of high-quality cell lines and execution of robust screening assay against a broad range of molecular targets.
At SB Drug Discovery, our services, built on expertise amassed across more than 20 years of global project work, help quickly generate trustworthy data and accelerate the discovery of novel therapeutics. Known globally for our cell line generation expertise, delivering challenging target solutions and in-depth functional characterization, our focus is on providing reagents to expedite discovery research.
Due to further expansion of our company, we are seeking to recruit a Junior Research Scientist to join our screening department. This role might suit a recently qualified life science graduate, or someone with relevant experience.
-
Assist in the production of cell lines, for cell-based assays.
-
Assist in screening assays against a broad range of molecular targets.
-
Support routine laboratory operations across all departments.
-
Educated to degree level in a Life Science subject.
-
Experience of working in a research or commercial laboratory environment will be advantageous.
-
Good social, communication & organisational skills and comfortable working within a team.
-
Enthusiasm, problem solving skills and the ability to analyse and interpret results.
In return you will receive an excellent training and benefits package, including a competitive salary which is reviewed annually, a bonus scheme, a well-regarded pension scheme, and private medical insurance. All our benefits are tailored to enhancing your experience at Sygnature as it is important to us that you share in our success.
We also recognise that the environment you work in is a priority, so we have built a collaborative and supportive culture with plenty of opportunities to grow and succeed, tailored to individual and business needs. This includes an excellent set of bespoke training and development courses to accelerate both your scientific and personal career growth.
Since 2011, 40 compounds discovered by Sygnature for customers have entered pre-clinical development. So far, 21 of these have progressed to clinical trials (Phases I, II and III). In 2017, Sygnature Discovery received the prestigious Queen’s Award for Enterprise for International Trade, in 2020 the Medilink Outstanding Achievement Award, and in 2021 the Bionow Company of the Year Award.
For more information, visit www.sygnaturediscovery.com/careers.
If you’re interested in joining a company that places people at the heart of its business, please apply through the link and include:
1) Your CV
2) Confirmation of your status of eligibility to work in the UK (we can consider sponsoring potential employees with relevant levels of qualifications and experience under a Skilled Worker Visa).
Your application will be submitted through our trusted partners, Lever, but only employees of Sygnature Discovery will review your application and personal data.
We will be interviewing on an ongoing basis, so please submit your application as soon as possible. We look forward to hearing from you.
If you have any questions or need further information, please contact the Careers team at
[email protected].
Please do not submit your application to this email address.